Latest Breaking News On - Marco purbhoo - Page 1 : comparemela.com

NEW YORK, Sept. 27, 2023 MiNK Therapeutics, Inc. , a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant.

New yorkUnited statesMarco purbhooMink therapeutics incSociety for immunotherapy of cancerHead of translational researchAnnual meetingTranslational research